在泌尿瘤中向整合素α5β1:机遇和挑战
Xuming Zhou1,2, Hezhen Zhu1,2, Cong Luo1,2
1The First Clinical College, Gannan Medical University, Ganzhou, China.
Frontiers in oncology
|July 24, 2023
概括
整蛋白α5β1在泌尿瘤转移和进展中至关重要. 准这种纤维内素受体为新的癌症治疗提供了潜力,特别是对抗性瘤.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 像前列腺,脏和膀癌这样的泌尿器官瘤正在增加.
- 这些癌症的远程转移是死亡的主要原因.
- 转移的机制仍然不完全理解.
研究的目的:
- 阐明整合素α5β1在泌尿癌中的作用和调节机制.
- 讨论整合素α5β1的临床应用,特别是在克服治疗耐药性方面.
- 探索整合素α5β1作为未来研究的潜在治疗点.
主要方法:
- 对尿道恶性瘤中的整合素α5β1现有文献的综述.
- 分析整合素α5β1与配体的相互作用及其在瘤细胞行为中的作用.
- 检查临床数据和研究关于治疗耐药性的研究.
主要成果:
- 整合素α5β1与瘤粘附,入侵,迁移和免疫逃生有关.
- 该受体在尿道癌的远程转移中发挥着重要作用.
- 它的参与治疗耐药性突出其临床相关性.
结论:
- 整体素α5β1是泌尿瘤进展和转移的关键调解剂.
- 向整合素α5β1为新型癌症疗法提供了一个有希望的策略.
- 对整合素α5β1进行进一步的研究是有必要的,以开发有效的治疗方法来对抗抗性泌尿道癌.
更多相关视频
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
9.0K
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
10.2K
相关概念视频
Integrins
4.0K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.0K
Activation of Integrins
3.5K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.5K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Selectins
3.4K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.4K
